NCT05891496: A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
- State
- Completed
- Phase
- Phase 3
- People
- 23 taking part
- Started
- 20 Jun 2023
- Primary completion
- 19 Aug 2024
- Arms
- Study intervention period 1
- Results
- Posted on the registry
- 7 Jun 2023: Trial registered
- 20 Jun 2023: Trial started
- 8 Sep 2025: Trial completed
- 24 Feb 2026: Trial results posted